Skip to content
Investing

Paladin Energy Profile: A Namibian Uranium Mine, a Canadian Growth Project and the Risks

Paladin Energy mines uranium at Langer Heinrich in Namibia and is developing Patterson Lake South in Canada, targeting first output in 2031. Here are its numbers, cash, risks and dates.

Aerial view of operations at the Langer Heinrich uranium mine in Namibia
Photo: Paladin Energy

Paladin Energy is one of the few listed uranium companies that already sells uranium from its own mine while also developing a large new one. Its shares give exposure to the uranium price through Langer Heinrich in Namibia, and to the much bigger promise, and risk, of Patterson Lake South in Canada.

Two Assets on Two Continents

Paladin is based in Perth, listed on the ASX and the Toronto Stock Exchange under PDN, and traded in the US over the counter as PALAF. Its business rests on two assets.

The first is the Langer Heinrich Mine (LHM), an open pit operation about 85km northeast of Walvis Bay in Namibia's Erongo Region. Paladin owns 75%; CNNC Overseas, part of China National Nuclear Corporation, holds the other 25%. The mine has produced more than 51 million pounds of uranium oxide (U3O8) to date, and 99% of its 420 employees are Namibian nationals.

The second is the Patterson Lake South (PLS) project in the Athabasca Basin region of Saskatchewan, acquired with Fission Uranium in December 2024. PLS hosts the high-grade Triple R deposit. Paladin also explores at the Michelin project in Canada and holds tenements in Australia.

Paladin Energy: share price, chart and news

Paladin's Patterson Lake South project site in Saskatchewan.
Paladin's Patterson Lake South project site in Saskatchewan. Photo: Paladin Energy

Langer Heinrich: A Slow Quarter, Then a Better October

In the September quarter, the first of Paladin's 2027 financial year, Langer Heinrich produced 1.00 million pounds of U3O8, down from 1.23 million pounds in the June quarter. A planned maintenance shutdown, low in-circuit inventory and ore that was harder to process as mining moved through the J pit all weighed on output. Plant recovery fell to 85%, at the bottom of the target range.

Lower volume pushed the cost of production up to US$61.6 a pound. Sales, however, rose in value: Paladin sold 1.16 million pounds at an average of US$79.4 a pound, up from US$70.6, as uranium prices rose and a larger share of its sales was at market-related prices.

October was stronger. Interim figures in Paladin's November presentation show 0.44 million pounds produced in that single month, at a feed grade of 524ppm, recovery of 89% and a cost of production of US$45.4 a pound.

Langer Heinrich (100% basis)Q1 FY2027Q4 FY2026October 2026
U3O8 produced1.00 Mlb1.23 Mlb0.44 Mlb
U3O8 sold1.16 Mlb1.35 Mlb0.54 Mlb
Average realised priceUS$79.4/lbUS$70.6/lbn/a
Cost of productionUS$61.6/lbUS$51.6/lbUS$45.4/lb

Paladin kept its guidance for the year to June 2027 of 5.1 to 5.6 million pounds at a cost of production of US$44 to US$48 a pound. Meeting it depends on a stronger second half, when higher-grade ore is due to reach the plant. A shutdown to install an upgraded kiln, planned for the December quarter, has been pushed into the second half because of the kiln's delivery schedule.

The group's interim accounts for the quarter show revenue of US$92.4 million, up from US$36.0 million a year earlier, gross profit of US$14.2 million and a small net loss of US$0.3 million after finance costs.

Patterson Lake South: The Growth Case

Triple R holds an indicated resource of 2.9 million tonnes at 1.88% U3O8, or 118.8 million pounds, and probable reserves of 3.0 million tonnes at 1.41%, or 93.7 million pounds. Paladin's August 2025 project update modelled average output of about 9.1 million pounds a year over an initial ten-year mine life, after a construction period of about three years.

PLS study figures (August 2025 update, at US$90/lb uranium)

  • Pre-production capital cost of US$1,226 million
  • Post-tax NPV of US$1,325 million at an 8% discount rate and IRR of 28.2%
  • All-in sustaining cost of US$15.2 a pound over the mine life
  • First production targeted in 2031

Permitting has moved forward. In July 2026 Paladin signed an administrative protocol with the Canadian Nuclear Safety Commission targeting completion of hearings on its construction licence application by the end of 2027. In August it signed a mutual benefits agreement with Birch Narrows Dene Nation, its third such agreement with Indigenous Nations. Drilling has also extended new zones at Atlas and Saloon East, about 3.5km from Triple R.

Cash, Debt, Shares and Risks

Balance sheet

  • US$209m cash and investments at 30 September 2026
  • A$525m equity raised in November 2026
  • 516.7m shares on issue pro forma, from 449.4m

At the end of September Paladin had US$209 million of cash and investments, US$28 million owed on its term loan and an undrawn US$70 million revolving credit facility. It also owed 400,000 pounds of uranium under product loans, half due in the March 2027 quarter and half in the September 2027 quarter.

On 12 and 13 November it raised A$525 million at A$7.80 a share to fund PLS early works in 2027 and 2028, more drilling and repayment of the term loan. Its presentation shows pro forma cash of about US$570 million. A share purchase plan for Australian and New Zealand holders seeks up to a further A$50 million.

The main risks for shareholders:

  • Operations: Langer Heinrich has yet to show steady output at guidance. Recovery, grade and the deferred kiln shutdown all affect whether the year's target is met.
  • Uranium price: Revenue depends on contract terms and the market price, which can fall as well as rise.
  • Funding PLS: The raising covers early works. Most of the US$1,226 million capital cost still needs debt, offtake or partner funding, and further equity cannot be ruled out.
  • Permits and schedule: PLS needs provincial approvals and federal licences. The CNSC protocol is non-binding, and Saskatchewan winters limit when work can be done.
  • Geopolitics and costs: Paladin cites conflict in the Middle East, energy costs and inflation among its risks, though it reported no supply disruption at Langer Heinrich last quarter.
  • No dividend: The company does not expect to pay dividends in the foreseeable future.

What to Watch Next

DateEvent
17 November 2026Annual general meeting in Perth
18 to 19 November 2026Settlement and allotment of the new placement shares
23 November to 7 December 2026Share purchase plan open; results due 14 December
December quarter reportLanger Heinrich output against the second-half ramp-up
Second half of FY2027Kiln upgrade shutdown at Langer Heinrich
End of 2027Targeted completion of CNSC construction licence hearings
2031Targeted first production at PLS

Sources

Related stories

Business

Paladin Energy Raises A$525 Million to Push Its Canadian PLS Uranium Project Towards 2031

The uranium miner sold about 67 million new shares at A$7.80, a 10.3% discount, to fund early works at Patterson Lake South in Saskatchewan, more drilling and the repayment of its…

Investing

Boss Energy Profile: Honeymoon, Alta Mesa and a Year of Transition for the Uranium Producer

Boss Energy mines uranium at Honeymoon in South Australia and owns 30% of Alta Mesa in Texas. It has no debt and a large stockpile, but output falls this year as it changes mining…

Investing

Denison Mines Investor Profile: Wheeler River, the Phoenix Build and the Road to 2028

Denison Mines is building Phoenix, a high-grade in-situ uranium mine in Saskatchewan, with first output targeted for late 2028. Its assets, latest numbers, funding, risks and the…

Investing

Atha Energy: Investor Profile of the Uranium Explorer Behind Nunavut's Angilak Project

Atha Energy explores for uranium at Angilak in Nunavut, in Labrador and in the Athabasca Basin. Its assets, latest reported numbers, cash, share count, main risks and the dates to…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…